Deerfield Management Company, L.P. (Series C) Oncology Institute, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,360,052 shares of TOI stock, worth $13.8 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
3,360,052
Previous 3,360,052
-0.0%
Holding current value
$13.8 Million
Previous $3.83 Million
79.84%
% of portfolio
0.16%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding TOI
# of Institutions
78Shares Held
27.9MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.28MShares$17.6 Million0.0% of portfolio
-
Tiff Advisory Services Inc3.63MShares$14.9 Million1.76% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.52MShares$10.4 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.75MShares$7.19 Million0.37% of portfolio
-
Marshall Wace, LLP London, X01.48MShares$6.07 Million0.0% of portfolio
About Oncology Institute, Inc.
- Ticker TOI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 73,495,504
- Market Cap $302M
- Description
- The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...